BG
SGNT

BlackRock Group’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

BlackRock Group’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-41,248
Closed -$619K – 3035
2016
Q2 		$619K Buy
41,248
+1,621
+4% +$20.8K ﹤0.01% 2182
2016
Q1 		$482K Buy
39,627
+2,525
+7% +$35.4K ﹤0.01% 2253
2015
Q4 		$591K Sell
37,102
-403
-1% -$6.34K ﹤0.01% 2127
2015
Q3 		$574K Sell
37,505
-57
-0.2% -$1.23K ﹤0.01% 2156
2015
Q2 		$913K Buy
37,562
+9,414
+33% +$226K ﹤0.01% 2000
2015
Q1 		$655K Buy
28,148
+2,010
+8% +$53.2K ﹤0.01% 2087
2014
Q4 		$656K Buy
26,138
+14,631
+127% +$429K ﹤0.01% 2121
2014
Q3 		$357K Buy
11,507
+11,107
+2,777% +$301K ﹤0.01% 2291
2014
Q2 		$10K Hold
400
– – ﹤0.01% 2795
2014
Q1 		$9K Hold
400
– – ﹤0.01% 2711
2013
Q4 		$10K Hold
400
– – ﹤0.01% 2626
2013
Q3 		$8K Hold
400
– – ﹤0.01% 2856
2013
Q2 		$8K Buy
+400
New +$7.15K ﹤0.01% 2579

BlackRock Group's SGNT Position: Q3 2016 in Review

BlackRock Group sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 41,248 shares — an estimated $619K sold.

BlackRock Group first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $913K in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • BlackRock Group reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • BlackRock Group sold 41,248 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $619K.
  • BlackRock Group first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • BlackRock Group's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $913K in Q2 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on BlackRock Group's 13F filing for Q3 2016, filed 8 Nov 2016.